A Novel Splice-Site Mutation in the ELN Gene Suggests an Alternative Mechanism for Vascular Elastinopathies

Camilo Andres Velandia-Piedrahita,1 Adrien Morel,2,* Dora Janeth Fonseca-Mendoza,2,* Victor Manuel Huertas-Quiñones,3– 5 David Castillo,6 Juan Diego Bonilla,7 Camilo José Hernandez-Toro,1 Marta Catalina Miranda-Fernández,1 Carlos Martin Restrepo,2 Rodrigo C...

Full description

Bibliographic Details
Main Authors: Velandia-Piedrahita CA, Morel A, Fonseca-Mendoza DJ, Huertas-Quiñones VM, Castillo D, Bonilla JD, Hernandez-Toro CJ, Miranda-Fernández MC, Restrepo CM, Cabrera R
Format: Article
Language:English
Published: Dove Medical Press 2020-12-01
Series:The Application of Clinical Genetics
Subjects:
eln
Online Access:https://www.dovepress.com/a-novel-splice-site-mutation-in-the-eln-gene-suggests-an-alternative-m-peer-reviewed-article-TACG
id doaj-049a534abdc345dbb61069c3b0889398
record_format Article
spelling doaj-049a534abdc345dbb61069c3b08893982020-12-17T19:03:36ZengDove Medical PressThe Application of Clinical Genetics1178-704X2020-12-01Volume 1323324060438A Novel Splice-Site Mutation in the ELN Gene Suggests an Alternative Mechanism for Vascular ElastinopathiesVelandia-Piedrahita CAMorel AFonseca-Mendoza DJHuertas-Quiñones VMCastillo DBonilla JDHernandez-Toro CJMiranda-Fernández MCRestrepo CMCabrera RCamilo Andres Velandia-Piedrahita,1 Adrien Morel,2,* Dora Janeth Fonseca-Mendoza,2,* Victor Manuel Huertas-Quiñones,3– 5 David Castillo,6 Juan Diego Bonilla,7 Camilo José Hernandez-Toro,1 Marta Catalina Miranda-Fernández,1 Carlos Martin Restrepo,2 Rodrigo Cabrera1,2 1Laboratorio de Biología Molecular y Pruebas Diagnósticas de Alta Complejidad, Fundación Cardioinfantil‐Instituto de Cardiología, Bogotá, Colombia; 2Center for Research in Genetics and Genomics-CIGGUR, GENIUROS Research Group, School of Medicine and Health Sciences, Universidad del Rosario, Bogotá, Colombia; 3Instituto de Cardiopatías Congénitas, Fundación Cardioinfantil‐Instituto de Cardiología, Bogotá, Colombia; 4Facultad de Medicina, Universidad Nacional de Colombia, Bogotá, Colombia; 5Facultad de Medicina, Universidad del Rosario, Bogotá, Colombia; 6Servicio de Dermatología, Fundación Para la Investigación en Dermatología FUNINDERMA, Bogotá, Colombia; 7Servicio de Dermatología, Universidad El Bosque, Bogotá, Colombia*These authors contributed equally to this workCorrespondence: Rodrigo CabreraLaboratorio de Biología Molecular y Pruebas Diagnósticas de Alta Complejidad, Fundación Cardioinfantil‐Instituto de Cardiología, Calle 163A # 13B-60, Bogotá CP 110131, ColombiaTel +57 1 6672727 ext 11611Fax +57 1 6672727 Ext 73206Email rcabrerap@cardioinfantil.orgAbstract: The ELN gene encodes elastin, a fundamental protein of the extracellular matrix that confers elasticity to different tissues including blood vessels. The formation of elastin fibers is a complex process involving monomer coacervation and subsequent crosslinking. Mutations in exons 1– 29 of the ELN gene have been linked to supravalvular aortic stenosis (SVAS) whereas mutations in exons 30– 33 are associated with autosomal dominant cutis laxa (ADCL). This striking segregation has led to the hypothesis that distinct molecular mechanisms underlie both diseases. SVAS is believed to arise through haploinsufficiency while ADCL is hypothesized to be caused by a dominant negative effect. Here, we describe a patient with SVAS harboring a novel splice-site mutation in the last exon of ELN. The location of this mutation is not consistent with current knowledge of SVAS, since all mutations reported in the C-terminus have been found in ADCL patients, and a thorough evaluation did not reveal significant skin involvement in this case. RT-PCR analysis of skin tissue showed that C-terminal mutations in the region can lead to the production of aberrant transcripts through intron retention and activation of cryptic splice sites and suggest that disruption of the very last exon can lead to functional haploinsufficiency potentially related to SVAS.Keywords: SVAS, ELN, ADCL, coacervation, splicinghttps://www.dovepress.com/a-novel-splice-site-mutation-in-the-eln-gene-suggests-an-alternative-m-peer-reviewed-article-TACGsvaselnadclcoacervationsplicing
collection DOAJ
language English
format Article
sources DOAJ
author Velandia-Piedrahita CA
Morel A
Fonseca-Mendoza DJ
Huertas-Quiñones VM
Castillo D
Bonilla JD
Hernandez-Toro CJ
Miranda-Fernández MC
Restrepo CM
Cabrera R
spellingShingle Velandia-Piedrahita CA
Morel A
Fonseca-Mendoza DJ
Huertas-Quiñones VM
Castillo D
Bonilla JD
Hernandez-Toro CJ
Miranda-Fernández MC
Restrepo CM
Cabrera R
A Novel Splice-Site Mutation in the ELN Gene Suggests an Alternative Mechanism for Vascular Elastinopathies
The Application of Clinical Genetics
svas
eln
adcl
coacervation
splicing
author_facet Velandia-Piedrahita CA
Morel A
Fonseca-Mendoza DJ
Huertas-Quiñones VM
Castillo D
Bonilla JD
Hernandez-Toro CJ
Miranda-Fernández MC
Restrepo CM
Cabrera R
author_sort Velandia-Piedrahita CA
title A Novel Splice-Site Mutation in the ELN Gene Suggests an Alternative Mechanism for Vascular Elastinopathies
title_short A Novel Splice-Site Mutation in the ELN Gene Suggests an Alternative Mechanism for Vascular Elastinopathies
title_full A Novel Splice-Site Mutation in the ELN Gene Suggests an Alternative Mechanism for Vascular Elastinopathies
title_fullStr A Novel Splice-Site Mutation in the ELN Gene Suggests an Alternative Mechanism for Vascular Elastinopathies
title_full_unstemmed A Novel Splice-Site Mutation in the ELN Gene Suggests an Alternative Mechanism for Vascular Elastinopathies
title_sort novel splice-site mutation in the eln gene suggests an alternative mechanism for vascular elastinopathies
publisher Dove Medical Press
series The Application of Clinical Genetics
issn 1178-704X
publishDate 2020-12-01
description Camilo Andres Velandia-Piedrahita,1 Adrien Morel,2,* Dora Janeth Fonseca-Mendoza,2,* Victor Manuel Huertas-Quiñones,3– 5 David Castillo,6 Juan Diego Bonilla,7 Camilo José Hernandez-Toro,1 Marta Catalina Miranda-Fernández,1 Carlos Martin Restrepo,2 Rodrigo Cabrera1,2 1Laboratorio de Biología Molecular y Pruebas Diagnósticas de Alta Complejidad, Fundación Cardioinfantil‐Instituto de Cardiología, Bogotá, Colombia; 2Center for Research in Genetics and Genomics-CIGGUR, GENIUROS Research Group, School of Medicine and Health Sciences, Universidad del Rosario, Bogotá, Colombia; 3Instituto de Cardiopatías Congénitas, Fundación Cardioinfantil‐Instituto de Cardiología, Bogotá, Colombia; 4Facultad de Medicina, Universidad Nacional de Colombia, Bogotá, Colombia; 5Facultad de Medicina, Universidad del Rosario, Bogotá, Colombia; 6Servicio de Dermatología, Fundación Para la Investigación en Dermatología FUNINDERMA, Bogotá, Colombia; 7Servicio de Dermatología, Universidad El Bosque, Bogotá, Colombia*These authors contributed equally to this workCorrespondence: Rodrigo CabreraLaboratorio de Biología Molecular y Pruebas Diagnósticas de Alta Complejidad, Fundación Cardioinfantil‐Instituto de Cardiología, Calle 163A # 13B-60, Bogotá CP 110131, ColombiaTel +57 1 6672727 ext 11611Fax +57 1 6672727 Ext 73206Email rcabrerap@cardioinfantil.orgAbstract: The ELN gene encodes elastin, a fundamental protein of the extracellular matrix that confers elasticity to different tissues including blood vessels. The formation of elastin fibers is a complex process involving monomer coacervation and subsequent crosslinking. Mutations in exons 1– 29 of the ELN gene have been linked to supravalvular aortic stenosis (SVAS) whereas mutations in exons 30– 33 are associated with autosomal dominant cutis laxa (ADCL). This striking segregation has led to the hypothesis that distinct molecular mechanisms underlie both diseases. SVAS is believed to arise through haploinsufficiency while ADCL is hypothesized to be caused by a dominant negative effect. Here, we describe a patient with SVAS harboring a novel splice-site mutation in the last exon of ELN. The location of this mutation is not consistent with current knowledge of SVAS, since all mutations reported in the C-terminus have been found in ADCL patients, and a thorough evaluation did not reveal significant skin involvement in this case. RT-PCR analysis of skin tissue showed that C-terminal mutations in the region can lead to the production of aberrant transcripts through intron retention and activation of cryptic splice sites and suggest that disruption of the very last exon can lead to functional haploinsufficiency potentially related to SVAS.Keywords: SVAS, ELN, ADCL, coacervation, splicing
topic svas
eln
adcl
coacervation
splicing
url https://www.dovepress.com/a-novel-splice-site-mutation-in-the-eln-gene-suggests-an-alternative-m-peer-reviewed-article-TACG
work_keys_str_mv AT velandiapiedrahitaca anovelsplicesitemutationintheelngenesuggestsanalternativemechanismforvascularelastinopathies
AT morela anovelsplicesitemutationintheelngenesuggestsanalternativemechanismforvascularelastinopathies
AT fonsecamendozadj anovelsplicesitemutationintheelngenesuggestsanalternativemechanismforvascularelastinopathies
AT huertasquinonesvm anovelsplicesitemutationintheelngenesuggestsanalternativemechanismforvascularelastinopathies
AT castillod anovelsplicesitemutationintheelngenesuggestsanalternativemechanismforvascularelastinopathies
AT bonillajd anovelsplicesitemutationintheelngenesuggestsanalternativemechanismforvascularelastinopathies
AT hernandeztorocj anovelsplicesitemutationintheelngenesuggestsanalternativemechanismforvascularelastinopathies
AT mirandafernandezmc anovelsplicesitemutationintheelngenesuggestsanalternativemechanismforvascularelastinopathies
AT restrepocm anovelsplicesitemutationintheelngenesuggestsanalternativemechanismforvascularelastinopathies
AT cabrerar anovelsplicesitemutationintheelngenesuggestsanalternativemechanismforvascularelastinopathies
AT velandiapiedrahitaca novelsplicesitemutationintheelngenesuggestsanalternativemechanismforvascularelastinopathies
AT morela novelsplicesitemutationintheelngenesuggestsanalternativemechanismforvascularelastinopathies
AT fonsecamendozadj novelsplicesitemutationintheelngenesuggestsanalternativemechanismforvascularelastinopathies
AT huertasquinonesvm novelsplicesitemutationintheelngenesuggestsanalternativemechanismforvascularelastinopathies
AT castillod novelsplicesitemutationintheelngenesuggestsanalternativemechanismforvascularelastinopathies
AT bonillajd novelsplicesitemutationintheelngenesuggestsanalternativemechanismforvascularelastinopathies
AT hernandeztorocj novelsplicesitemutationintheelngenesuggestsanalternativemechanismforvascularelastinopathies
AT mirandafernandezmc novelsplicesitemutationintheelngenesuggestsanalternativemechanismforvascularelastinopathies
AT restrepocm novelsplicesitemutationintheelngenesuggestsanalternativemechanismforvascularelastinopathies
AT cabrerar novelsplicesitemutationintheelngenesuggestsanalternativemechanismforvascularelastinopathies
_version_ 1724379066783498240